Skip to main content
Fig. 2 | The Journal of Headache and Pain

Fig. 2

From: Functionality, satisfaction, and global impression of change with ubrogepant for the acute treatment of migraine in triptan insufficient responders: a post hoc analysis of the ACHIEVE I and ACHIEVE II randomized trials

Fig. 2

Proportion of participants reporting ability to function normally on the FDS in (a) TIR and (b) TIR due to insufficient efficacy groups. FDS, Functional Disability Scale; OR, odds ratio; TIR, triptan insufficient responder. P-values are based on logistic regression with treatment group, use of medication for migraine prevention, and baseline headache severity as covariates; last observation carried forward approach was used to input missing values post baseline

Back to article page